Covid-19: DCGI grants restricted emergency-use nod to Corbevax vaccine for 12-18 age group
According to the health ministry, the company has conducted phase 1/2 and 2/3 clinical trials of its COVID-19 vaccine in the country. The Drugs Controller General of India has granted restricted emergency use authorisation (EUA) to Biological E’s COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official sources … Read more
